Evidence for Leishmania (Viannia) parasites in the skin and blood of patients before and after treatment

Journal of Infectious Diseases

Volumn 194, Issue 4, 2006, Pages 503-511

  Vergel, Carolina ^a   Palacios, Ricardo ^a,b   Cadena, Horacio ^a   Posso, Claudia Jimena ^a   Valderrama, Liliana ^a   Perez, Mauricio ^a   Walker, John ^a   Travi, Bruno Luis ^a,c   Saravia, Nancy Gore ^a  

^a CENTRO INTERNACIONAL DE ENTRENAMIENTO E INVESTIGACIONES MÉDICAS CIDEIM   (Colombia)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^c UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MEGLUMINE ANTIMONATE;

ADOLESCENT; ADULT; ARTICLE; DISEASE TRANSMISSION; DOMESTICATION; FEMALE; HUMAN; LEISHMANIA; MAJOR CLINICAL STUDY; MALE; MONOCYTE; PARASITE ISOLATION; PARASITOSIS; PERIPHERAL BLOOD MONONUCLEAR CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SKIN CULTURE; SKIN LEISHMANIASIS; SOUTHERN BLOTTING; XENODIAGNOSIS; ZOONOSIS;

ADOLESCENT; ADULT; ANIMALS; ANTIPROTOZOAL AGENTS; CICATRIX; DISEASE RESERVOIRS; DNA, PROTOZOAN; FEMALE; HUMANS; INSECT VECTORS; LEISHMANIA; LEISHMANIASIS, CUTANEOUS; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PSYCHODIDAE; SKIN;

EID: 33746687863     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/505583     Document Type: Article

References (49)

1. Campbell-Lendrum D, Dujardin JP, Martinez E, et al. Domestic and peridomestic transmission of American cutaneous leishmaniasis: changing epidemiological patterns present new control opportunities. Mem Inst Oswaldo Cruz 2001; 96:159-62.
2. Bejarano EE, Uribe S, Rojas W, Dario Velez I. Phlebotomine sand flies (Diptera: Psychodidae) associated with the appearance of urban leishmaniasis in the city of Sincelejo, Colombia. Mem Inst Oswaldo Cruz 2002; 97:645-7.
3. Oliveira CC, Lacerda HG, Martins DR, et al. Changing epidemiology of American cutaneous leishmaniasis (ACL) in Brazil: a disease of the urban-rural interface. Acta Trop 2004; 90:155-62.
4. Leonardo FS, Rebêlo JM. A periurbanização de Lutzomyia whitmani em área de foco de leishmaniose cutânea, no Estado do Maranhão, Brasil. Rev Soc Bras Med Trop 2004; 37:282-4.
5. Desjeux P. Leishmaniasis: current situation and new perspectives. Comp Immunol Microbiol Infect Dis 2004; 27:305-18.
6. Soto J, Toledo J, Vega J, Berman J. Short report: efficacy of pentavalent antimony for treatment of Colombian cutaneous leishmaniasis. Am J Trop Med Hyg 2005; 72:421-2.
7. Palacios R, Osorio LE, Grajalew LF, Ochoa MT. Treatment failure in children in a randomized clinical trial with 10 and 20 days of meglumine antimonate for cutaneous leishmaniasis due to Leishmania [Viannia] species. Am J Trop Med Hyg 2001; 64:187-93.
8. Romero GA, Guerra MV, Paes MG, Macedo VO. Comparison of cutaneous leishmaniasis due to Leishmania [Viannia] braziliensis and L. [V] guyanensis in Brazil: therapeutic response to meglumine antimoniate. Am J Trop Med Hyg 2001; 65:456-65.
9. Alvar J, Canavate C, Gutierrez-Solar B, et al. Leishmania and human immunodeficiency virus coinfection: the first 10 years. Clin Microbiol Rev 1997; 10:298-319.
10. Bourreau E, Prevot G, Gardon J, Pradinaud R, Launois P. High intralesional interleukin-10 messenger RNA expression in localized cutaneous leishmaniasis is associated with unresponsiveness to treatment. J Infect Dis 2001; 184:1628-30.
11. Lira R, Sundar S, Makharia A, et al. Evidence that the high incidence of treatment failures in Indian kala-azar is due to the emergence of antimony-resistant strains of Leishmania donovani. J Infect Dis 1999; 180:564-7.
12. Rojas R, Valderrama L, Valderrama M, Varona MX, Ouellette M, Saravia NG. Resistance to antimony and treatment failure in human Leishmania (Viannia) infection. J Infect Dis 2006; 193:1375-83.
13. Travi BL, Montoya J, Solarte Y, Lozano L, Jaramillo C. Studies on the phlebotomine fauna associated with endemic foci in the Pacific Coiast region. Am J Trop Med Hyg 1988; 39:261-6.
14. Montoya-Lerma J, Palacios R, Osorio L, Jaramillo C, Cadena H. Further evidence of humans as a source of Leishmania [Viannia] for sand flies. Mem Inst Oswaldo Cruz 1998; 93:735-6.
15. Schubach A, Haddad F, Oliveira-Neto MP, et al. Detection of Leishmania DNA by polymerase chain reaction in scars of treated human patients. J Infect Dis 1998; 178:911-4.
16. Guevara P, Rojas E, Gonzalez N, et al. Presence of Leishmania braziliensis in blood samples from cured patients or at different stages of immunotherapy. Clin Diagn Lab Immunol 1994; 1:385-9.
17. Schubach A, Marzochi MC, Cuzzi-Maya T, et al. Cutaneous scars in American tegumentary leishmaniasis patients: a site of Leishmania [Viannia] braziliensis persistence and viability eleven years after antimonial therapy and clinical cure. Am J Trop Med Hyg 1998; 58:824-7.
18. Saravia NG, Weigle K, Segura I, et al. Recurrent lesions in human Leishmania braziliensis infection-reactivation or reinfection? Lancet 1990; 336:398-402.
19. Ward RD, Lainson R, Shaw JJ. Some methods for membrane feeding of laboratory reared neotropical sandflies (Diptera: Psychodidae). Ann Trop Med Parasitol 1978; 72:269-76.
20. Weigle KA, de Davalos M, Heredia P, Molineros R, Saravia NG, D'Alessandro A. Diagnosis of cutaneous and mucocutaneous leishmaniasis in Colombia: a comparison of seven methods. Am J Trop Med Hyg 1987; 36:489-96.
21. Vergel C, Walker J, Saravia N. Amplification of human DNA by primers targeted to Leishmania kDNA and post-genome considerations in diagnostic PCR. Am J Trop Med Hyg 2005; 72:423-9.
22. Brujin M, Barker D. Diagnosis of New World leishmaniasis: specific detection of species of the Leishmania braziliensis complex by amplification of kinetoplast DNA. Acta Trop 1992; 52:45-8.
23. Weigle K, Labrada LA, Lozano C, Santrich C, Barker D. PCR-based diagnosis of acute and chronic cutaneous leishmaniasis caused by Leishmania [Viannia]. J Clin Microbiol 2002; 40:601-6.
24. Saravia NG, Weigle K, Navas C, et al. Heterogeneity, geographic distribution, and pathogenicity of serodemes of Leishmania [Viannia] in Colombia. Am J Trop Med Hyg 2002; 66:738-44.
25. Saravia NG, Segura I, Holguin AF, Santrich C, Valderrama L, Ocampo C. Epidemiologic, genetic, and clinical associations among phenotypically distinct populations of Leishmania [Viannia] in Colombia. Am J Trop Med Hyg 1998; 59:86-94.
26. Desjeux P. The increase in risk factors for leishmaniasis worldwide. Trans R Soc Trop Med Hyg 2001; 95:239-43.
27. Yadon ZE, Rodrigues LC, Davies CR, Quigley MA. Indoor and peridomestic transmission of American cutaneous leishmaniasis in north-western Argentina: a retrospective case control study. Am J Trop Med Hyg 2003; 68:519-26.
28. Costa CH, Gomes RB, Silva MR, et al. Competence of the human host as a reservoir for Leishmania chagasi. J Infect Dis 2000; 182:997-1000.
29. Rojas E, Scorza JV. Xenodiagnostico con Lutzomyia youngi en casos venozolanos de leishmaniasis cutanea por Leishmania braziliensis. Mem Inst Oswaldo Cruz 1989; 84:29-34.
30. Deane L, Rangel E, Paes-Oliveira M, et al. Experimental infection of Lutzomyia longipalpis fed on a patient with cutaneous leishmaniasis due to Leishmania mexicana amazonensis. Mem Inst Oswaldo Cruz 1986; 81:133-4.
31. Mendonça MG, de Brito M, Rodrigues E, Bandeira V, Jardim ML, Abath F. Persistence of Leishmania parasites in scars after clinical cure of American cutaneous leishmaniasis: is there a sterile cure? J Infect Dis 2004; 189:1018-23.
32. Coutinho SG, Pirmez C, Da-Cruz AM. Parasitological and immunological follow-up of American tegumentary leishmaniasis patients. Trans R Soc Trop Med Hyg 2002; 96(Suppl 1):S173-8.
33. Weigle KA, Santrich C, Martínez F, et al. Epidemiology of cutaneous leishmaniasis in Colombia: environmental and behavioral risk factors for infection, clinical manifestations, and pathogenicity. J Infect Dis 1993; 168:709-14.
34. Courtenay O, Quinnell RJ, Garcez LM, Shaw JJ, Dye C. Infectiousness in a cohort of Brazilian dogs: why culling fails to control visceral leishmaniasis in areas of high transmission. J Infect Dis 2002; 186:1314-20.
35. Le Fichoux Y, Quaranta JF, Aufeuvre JP, et al. Occurrence of Leishmania infantum parasitemia in asymptomatic blood donors living in an area of endemicity in southern France. J Clin Microbiol 1999; 37:1953-7.
36. Martín-Sánchez J, Pineda J, Morillas-Márquez F, García-García J, Acedo C, Macías J. Detection of Leishmania infantum kinetoplast DNA in peripheral blood from asymptomatic individuals at risk for parentally transmitted infections: relationship between polymerase chain reaction results and other Leishmania infection markers. Am J Trop Med Hyg 2004; 70:545-8.
37. Otero AC, da Silva VO, Luz KG, et al. Short report: occurrence of Leishmania donovani DNA in donated blood from seroreactive Brazilian blood donors. Am J Trop Med Hyg 2000; 62:128-31.
38. Travi BL, Tabares CJ, Cadena H, Ferro C, Osorio Y. Canine visceral leishmaniasis in Colombia: relationship between clinical and parasitologic status and infectivity for sand flies. Am J Trop Med Hyg 2001; 64: 119-24.
39. de Oliveira CI, Báfica A, Oliveira F, Favali CBF, Correa T, Freitas LAR. Clinical utility of polymerase chain reaction-based detection of Leishmania in the diagnosis of American cutaneous leishmanisis. Clin Infect Dis 2003; 37:e149-53.
40. Marfurt J, Nasereddin A, Niederwieser I, Jaffe CL, Beck HP, Felger I. Identification and differentiation of Leishmania species in clinical samples by PCR amplification of the miniexon sequence and subsequent restriction fragment length polymorphism analysis. J Clin Microbiol 2003; 41:3147-53.
41. Workowski KA, Lampe MF, Wong KG, Watts MB, Stamm WE. Long-term eradication of Chlamydia trachomatis genital infection after antimicrobial therapy: evidence against persistent infection. JAMA 1993; 270:2071-5.
42. Disch J, Oliveira MC, Orsini M, Rabello A. Rapid clearance of circulating Leishmania kinetoplast DNA after treatment of visceral leishmaniasis. Acta Tropica 2004; 92:279-83.
43. Van der Meide WF, Schoone GJ, Faber WR, et al. Quantitative nucleic acid sequence-based assay as a new molecular tool for detection and quantification of Leishmania parasites in skin biopsy samples. J Clin Microbiol 2005; 43:5560-6.
44. Lamothe J. Use of meglumine antimoniate in canine leishmaniasis. Vet Rec 2004; 154:378.
45. Murray HW, Berman JD, Davies CR, Saravia NG. Advances in leishmaniasis. Lancet 2005; 366:1561-77.
46. Feliciangeli MD. Hourly activity of Lutzomyia ovallesi and L. gomezi (Diptera: Psychodidae), vectors of cutaneous leishmaniasis in north-central Venezuela. J Med Entomol 1997; 34:110-5.
47. Oliveira-Neto MP, Pirmez C, Rangel E, Schubach A, Grimaldi G. An outbreak of American cutaneous leishmaniasis (Leishmania braziliensis braziliensis) in a periurban area of Rio de Janiero city, Brazil: clinical and epidemiological studies. Mem Inst Oswaldo Cruz 1988; 83:427-35.
48. Martinez E, Le Pont F, Torrez M, et al. A new focus of cutaneous leishmaniasis due to Leishmania amazonensis in a sub-Andean region of Bolivia. Acta Trop 1998; 71:97-106.
49. Torrez M, Lopez M, Le Pont F, et al. Lutzomyia nuneztovari anglesi (Diptera: Psychodidae) as a probable vector of Leishmania braziliensis in the Yungas, Bolivia. Acta Trop 1998; 71:311-6.